LONG-TERM SAFETY AND EFFICACY OF CANAKINUMAB IN PATIENTS WITH CAPS: FINAL RESULTS FROM THE BETA-CONFIDENT REGISTRY

被引：1

作者：

Kuemmerle-Deschner, J. B. ^{[1
]}

Hoffman, H. ^{[2
]}

Hawkins, P. N. ^{[3
]}

van der Poll, T. ^{[4
]}

Walker, U. A. ^{[5
]}

Speziale, A. ^{[6
]}

Tilson, H. H. ^{[7
]}

Joubert, Y. ^{[6
]}

机构：

[1] Univ Hosp Tuebingen, Tubingen, Germany

[2] Univ Calif San Diego, La Jolla, CA 92093 USA

[3] UCL, Sch Med, London, England

[4] Univ Amsterdam, Acad Med Ctr, Amsterdam, Netherlands

[5] Univ Hosp, Basel, Switzerland

[6] Novartis Pharma AG, Basel, Switzerland

[7] Univ N Carolina, Chapel Hill, NC USA

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷

关键词：

D O I：

10.1136/annrheumdis-2016-eular.3827

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

FRI0492

引用

页码：617 / 617

页数：1

共 50 条

[1] Safety and Efficacy of Long-Term Canakinumab Therapy in Patients with CAPS: Final Results from Beta-Confident Registry
Hoffman, Hal M.
Kuemmerle-Deschner, Jasmin B.
Hawkins, Philip N.
van der Poll, Tom
Walker, Ulrich A.
Speziale, Antonio
Joubert, Yolandi
Tilson, Hugh H.
ARTHRITIS & RHEUMATOLOGY, 2016, 68
[2] Safety and Efficacy of Canakinumab in Patients with Caps: Interim Results from the Beta-confident Registry
Hoffman, Hal M.
Kuemmerle-Deschner, Jasmin B.
Hawkins, Philip N.
van der Poll, Tom
Walker, Ulrich A.
Speziale, Antonio
Tilson, Hugh H.
PEDIATRICS, 2018, 141
[3] Safety and Efficacy of Canakinumab in Patients with CAPS: Interim Results from the Beta-Confident Registry
Kuemmerle-Deschner, Jasmin B.
Hoffman, Hal M.
Hawkins, Philip N.
van der Poll, T.
Walker, Ulrich A.
Speziale, Antonio
Tilson, Hugh H.
ARTHRITIS & RHEUMATOLOGY, 2015, 67
[4] Long-term safety and efficacy of Canakinumab in cryopyrin-associated periodic syndrome (CAPS) patients: Results from beta-confident registry
Kuemmerle-Deschner J.
Hoffman H.
Hawkins P.N.
van der Poll T.
Walker U.A.
Speziale A.
Tilson H.H.
Pediatric Rheumatology, 13 (Suppl 1)
[5] EVALUATION OF LONG-TERM SAFETY AND EFFECTIVENESS OF CANAKINUMAB THERAPY IN PATIENTS WITH CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME: RESULTS FROM BETA-CONFIDENT REGISTRY
Kuemmerle-Deschner, J.
Hoffman, H.
Hawkins, P.
van der Poll, T.
Walker, U.
Speziale, A.
Tilson, H.
ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 850 - 850
[6] Canakinumab Use in Patients with Cryopyrin-Associated Periodic Syndrome: Interim Safety and Efficacy Results from Beta-Confident Registry.
Hoffman, Hal M.
Kuemmerle-Deschner, Jasmin B.
Hawkins, Philip N.
van der Poll, T.
Walker, Ulrich A.
Abrams, Ken
Tilson, Hugh H.
ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S367 - S367
[7] Long-term safety and effectiveness of canakinumab therapy in patients with cryopyrin-associated periodic syndrome: results from the β-Confident Registry
Walker, Ulrich A.
Tilson, Hugh H.
Hawkins, Philip N.
van der Poll, Tom
Noviello, Stephanie
Levy, Jeremy
Vritzali, Eleni
Hoffman, Hal M.
Kuemmerle-Deschner, Jasmin B.
RMD OPEN, 2021, 7 (02):
[8] SAFETY RESULTS FROM THE B-CONFIDENT REGISTRY IN CANAKINUMAB-TREATED PATIENTS WITH CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME (CAPS)
Kuemmerle-Deschner, J. B.
Tilson, H.
Hawkins, P. N.
van der Poll, T.
Walker, U. A.
Rauer, B.
Nebesky, J. M.
Kim, D.
Davis, N.
Hoffman, H.
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 321 - 321
[9] Safety Results From The Beta Confident Registry In Canakinumab-Treated Patients With Cryopyrin-Associated Periodic Syndrome.
Hoffman, Hal
Kuemmerle-Deschner, Jasmin B.
Hawkins, Philip N.
van der Poll, T.
Walker, Ulrich A.
Nebesky, Michael
Abrams, Ken
Tilson, Hugh
ARTHRITIS AND RHEUMATISM, 2013, 65 : S1173 - S1173
[10] LONG-TERM EFFECTIVENESS OF CANAKINUMAB IN AID - INTERIM ANALYSIS OF THE CAPS SUBGROUP FROM THE RELIANCE REGISTRY
Blank, N.
Borte, M.
Foeldvari, I.
Horneff, G.
Kallinich, T.
Kortus-Goetze, B.
Oommen, P.
Schuetz, C.
Weller-Heinemann, F.
Weber-Arden, J.
Kuemmerle-Deschner, J. B.
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1207 - 1207

← 1 2 3 4 5 →